Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?

Ling, Diane C; Vargo, John A; Beriwal, Sushil

Ling, Diane C; Vargo, John A; Beriwal, Sushil.

Ling DC; Department of Radiation Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital, Pittsburgh, Pennslyvania.
Vargo JA; Department of Radiation Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital, Pittsburgh, Pennslyvania.
Beriwal S; Department of Radiation Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital, Pittsburgh, Pennslyvania. Electronic address: beriwals@upmc.edu.

Int J Radiat Oncol Biol Phys ; 108(2): 390-393, 2020 10 01.

Article in English | MEDLINE | ID: covidwho-739851

Subject(s)

Breast Neoplasms/radiotherapy; COVID-19/epidemiology; Prostatic Neoplasms/radiotherapy; Radiation Dose Hypofractionation/standards; Rectal Neoplasms/radiotherapy; Chemoradiotherapy/methods; Chemoradiotherapy/standards; Evidence-Based Medicine; Female; Humans; Male; Radiosurgery; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatic Neoplasms / Rectal Neoplasms / Breast Neoplasms / Radiation Dose Hypofractionation / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Language: English Journal: Int J Radiat Oncol Biol Phys Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google